Iain Wilkie

Stock Analyst at Morgans

(0.11)
# 4,675
Out of 5,004 analysts
156
Total ratings
30.9%
Success rate
-12.9%
Average return

Stocks Rated by Iain Wilkie

Neurizon Therapeutics Limited
Sep 16, 2026
Reiterated: Buy
Price Target: $0.20
Current: $0.08
Upside: +159.74%
Echo IQ Limited
Sep 9, 2026
Reiterated: Buy
Price Target: $1.85 → $1.10
Current: $0.59
Upside: +86.44%
Clinuvel Pharmaceuticals Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $13.00 → $10.00
Current: $8.02
Upside: +24.69%
ImExHS Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $0.50 → $0.37
Current: $0.33
Upside: +13.85%
Mach7 Technologies Limited
Aug 31, 2026
Reiterated: Buy
Price Target: $0.44 → $0.48
Current: $0.24
Upside: +104.26%
SomnoMed Limited
Aug 31, 2026
Reiterated: Buy
Price Target: $0.75 → $0.76
Current: $0.32
Upside: +137.50%
Pro Medicus Limited
Aug 19, 2026
Reiterated: Buy
Price Target: $230.00
Current: $161.00
Upside: +42.86%
Microba Life Sciences Limited
Jul 16, 2026
Reiterated: Buy
Price Target: $0.12
Current: $0.05
Upside: +135.29%
Nanosonics Limited
Feb 25, 2026
Reiterated: Buy
Price Target: $5.00 → $4.00
Current: $2.95
Upside: +35.59%
Proteomics International Laboratories Ltd
Feb 2, 2026
Downgraded: Sell
Price Target: $0.43
Current: $0.12
Upside: +273.91%
Reiterated: Buy
Price Target: $0.58 → $0.24
Current: $0.00
Upside: n/a
Reiterated: Buy
Price Target: $0.22 → $0.29
Current: $0.02
Upside: n/a
Downgraded: Sell
Price Target: $1.28 → $0.78
Current: $0.25
Upside: n/a
Reiterated: Buy
Price Target: $1.43
Current: $0.09
Upside: n/a
Reiterated: Buy
Price Target: $1.31 → $1.24
Current: $0.28
Upside: n/a
Reiterated: Buy
Price Target: $1.89 → $1.64
Current: $0.02
Upside: n/a